Investing.com - Sensei Biotherapeutics (NASDAQ: SNSE) reported fourth quarter EPS of $-0.30, better than the analyst estimate of $-0.31. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Sensei Biotherapeutics's stock price closed at $0.77. It is up 11.59% in the last 3 months and down -49.10% in the last 12 months.
Sensei Biotherapeutics saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Sensei Biotherapeutics's stock price’s past reactions to earnings here.
According to InvestingPro, Sensei Biotherapeutics's Financial Health score is "fair performance".
Check out Sensei Biotherapeutics's recent earnings performance, and Sensei Biotherapeutics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar